Clinical Trials in Ourense, Spain
1 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC1,310 enrolled281 locationsNCT06136624
Recruiting
Phase 3
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen154 enrolled128 locationsNCT06430866
Recruiting
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
Non-small Cell Lung Cancer
AstraZeneca500 enrolled25 locationsNCT06068049
Recruiting
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Genitourinary Cancers
Spanish Oncology Genito-Urinary Group500 enrolled84 locationsNCT06724159
Recruiting
Phase 2
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Fundación GECP37 enrolled20 locationsNCT07242547
Recruiting
Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo740 enrolled243 locationsNCT05215340
Recruiting
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group8,000 enrolled73 locationsNCT03390894
Recruiting
Phase 3
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Lung Diseases
Fundación GECP129 enrolled30 locationsNCT06431633
Recruiting
Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co., Ltd.756 enrolled156 locationsNCT06095583